BioMarin Pharmaceutical, Inc. (BMRN)
57.02
-0.16
(-0.28%)
USD |
NASDAQ |
Jan 23, 10:15
BioMarin Pharmaceutical Price: 57.02 for Jan. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.29 |
| Gilead Sciences, Inc. | 133.35 |
| Merck & Co., Inc. | 107.64 |
| AbbVie, Inc. | 218.25 |
| Biogen, Inc. | 171.66 |
Price Related Metrics
| PE Ratio | 21.36 |
| PS Ratio | 3.614 |
| PEG Ratio | 0.3519 |
| Price to Book Value | 1.809 |
| Price to Free Cash Flow | 13.50 |
| Earnings Yield | 4.68% |
| Market Cap | 10.95B |
| PEGY Ratio | 0.3519 |
| Operating PE Ratio | 13.03 |
| Normalized PE Ratio | 15.98 |